Association of osteoporosis and skeletal muscle loss with serum type I collagen carboxyl-terminal peptide ß glypeptide: A cross-sectional study in elder Chinese population.

Type I collagen carboxyl-terminal peptide ß (ß-CTX) increases in osteoporosis. The study aimed to explore the relationship between serum ß-CTX and the risk of osteoporosis as well as sarcopenia in Chinese elderly inpatients. Around 228 patients whose age >65 years were recruited in this cross-sectional study. Dual-energy X-ray scanning was used to access skeletal muscle and bone mass. Serum concentration of ß-CTX as well as the prevalence of osteoporosis were significantly higher in low skeletal muscle index (SMI) group than that in the normal SMI group (P < 0.05). Serum ß-CTX levels negatively correlated with SMI and bone mass (P < 0.05). Total muscle mass, appendicular skeletal muscle mass, SMI, total bone mass, and bone mass at various sites including the limbs, spine, and pelvis decreased significantly, and the prevalence of low SMI increased with the increase of the quartiles of ß-CTX. Higher serum ß-CTX had an increased risk of low SMI and osteoporosis (P < 0.05). Summarily, with increasing serum ß-CTX levels, both muscle and bone mass decreased in Chinese elderly inpatients. Serum ß-CTX was positively associated with the risk of not only osteoporosis but also skeletal muscle loss.